FSR and the Global Genes Foundation Alliance Leadership Council
FSR is excited to announce that our Executive Director, Ginger Spitzer, is now on the Global Genes Foundation Alliance Leadership Council!
FSR is excited to announce that our Executive Director, Ginger Spitzer, is now on the Global Genes Foundation Alliance Leadership Council!
The Orphan Drug Act has been helping sarcoidosis patients receive better treatment options for the last 35 years. Help us ensure its future!
We are thrilled to announce that applications are now being accepted for the 2019-2020 term of the FSR Patient Ambassador Program.
In 2019 the Clinical Studies Network (CSN) will conduct a study focused on cardiac sarcoidosis at all 12 of our sites.